Outlining one country’s unique price-setting model for novel drugs-and the resulting pre-launch strategies for manufacturers.
Catarina Costa Pinheiro
Advertisement
Articles by Catarina Costa Pinheiro
Advertisement
Latest Updated Articles
CMED: The ‘Curupira’ of Brazil’s Pharma MarketPublished: February 21st 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
